TAZLOC CT 40MG TABLET is a combination of Chlorthalidone and Telmisartan which belongs to the group of medicines called Diuretics and Angiotensin II receptor blockers, respectively. It is used to manage essential hypertension (high blood pressure) in affected individuals when monotherapy with chlorthalidone or telmisartan becomes inadequate to control the condition.

It is also used as an initial therapy in patients who are indicated for multiple drug therapy to control high blood pressure.

TAZLOC CT 40MG TABLET is not recommended for use in patients allergic to chlorthalidone, telmisartan, and/or any sulphonamide derived medicines. It is also not recommended for use in patients suffering from anuria (failure of kidneys to produce urine) and severe liver impairment.

Before taking TAZLOC CT 40MG TABLET, inform your doctor if you have liver problems (such as mild to moderate hepatic impairment), kidney problems (such as decreased renal function, severe renal impairment, nephrogenic diabetes insipidus), and/or heart problems (such as congestive heart failure).

TAZLOC CT 40MG TABLET is not recommended for use in during pregnancy and in women planning for pregnancy. It is also not recommended for use in breastfeeding women since it passes through breastmilk.

TAZLOC CT 40MG TABLET should be used with caution in children and adolescents (aged 6 to 18 years) and in elders (aged 65 years and above). Consult your doctor before taking the medicine.

The most common side-effects of taking TAZLOC CT 40MG TABLET are back pain, sore throat, nausea, abdominal pain, indigestion, diarrhoea, and/or headache. Consult your doctor if any of these symptoms worsens.